Pregabalin Market Is To Reach USD 2.3 Billion 2032, Growing At A Rate Of 3.6% To Forecast 2024-2032

(EMAILWIRE.COM, September 19, 2024 ) Pune, 19 September 2024: The Pregabalin Market Size Was Valued at USD 1.7 Billion in 2023, and is Projected to Reach USD 2.3 Billion by 2032, Growing at a CAGR of 3.6% From 2024-2032.

Pregabalin is a medication that is used to treat epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, and generalised anxiety disorder. It is a medication for epilepsy that is utilised for the treatment of partial seizures. It works by reducing nerve activity and decreasing pain. Pregabalin, known as LYRICA, is a sedative drug used for neuropathic pain, epilepsy, and anxiety disorders. The market has grown due to its effectiveness, ageing population, and mental health awareness. Despite patent expiration and new competitors, Lyrica remains popular due to its reliability and minimal side effects. North America is the primary market, followed by Europe and Asia-Pacific. Research continues to expand its uses, but regulatory constraints, potential side effects, and consumer surveillance are concerns shaping the market’s future.

Get a Free Sample PDF of this Research Report for more Insights

https://introspectivemarketresearch.com/request/16992

Pregabalin’s Key Competitors include:

Pfizer Inc. (U.S.)

GlaxoSmithKline plc (UK)

Novartis AG (Switzerland)

Mylan N.V. (U.S.)

Teva Pharmaceutical Industries Ltd. (Israel)

Sanofi (France)

Hoffmann-La Roche Ltd. (Switzerland)

Aurobindo Pharma (India)

Lupin (India)

Zydus Cadila (India)

Amneal Pharmaceuticals LLC. (U.S.)

Cipla Inc. (U.S.)

Torrent Pharmaceuticals Ltd. (India)

Glenmark Pharmaceuticals Limited (India)

Medley Pharmaceuticals Ltd. (India)

Genesis Biotec Inc. (India)

Biomax Pharmaceutical Company (UK)

ZCL Chemicals Ltd. (India), and Other Major Players.

Pregabalin Market Dynamics

The increasing prevalence of epilepsy, extensive use of Lyrica for fibromyalgia and nerve pain, rising geriatric population with neuropathic pain and anxiety disorders, and growing investments in healthcare facilities are key drivers of the pregabalin market’s growth. The World Health Organization reports that 50 million people globally have epilepsy, with limited access to treatment. Lyrica is approved for fibromyalgia and nerve pain, affecting millions in the US. The elderly population faces age-related health issues that pregabalin can address effectively, leading to increased demand for the drug.

The healthcare market is growing with a focus on improving facilities and infrastructure. Partnerships and collaborations between public and private sectors are creating market opportunities. Research for new uses of pregabalin can lead to increased market share. Collaborations between pharmaceutical companies, research institutions, and healthcare providers can drive growth. The expiration of patents and generic competition may reduce market share. Side effects and safety concerns can also impact usage. Intense competition and market saturation are challenges for companies in the pregabalin market.

Pregabalin Market Regional Insights

North America is expected to have significant market growth over the forecast period. The growth in the pregabalin market in North America is being driven by factors such as the increasing prevalence of epilepsy and related diseases, the growing elderly population, the strong presence of key market players, and the availability of pregabalin in the region. In the United States, the high number of individuals suffering from epilepsy is expected to boost market expansion. Additionally, the rising rates of depression, anxiety, and PTSD in Canada are projected to increase the demand for pregabalin. Furthermore, the approval of new pregabalin products by the USFDA is anticipated to further drive market growth in the region.

Request Sample of the Report

https://introspectivemarketresearch.com/request/16992

Pregabalin Market Segment Analysis

By Product Type

Tablets and Capsules

Others

Based on Type, the Tablets and Capsules segment is expected to dominate the market during the forecast period. The tablets and capsules sector of the pregabalin market is projected to see substantial growth in the foreseeable future because of their broad use, precise dosing, and patient preference for oral solid dosage forms (OSDF). These items are commonly used in hospitals and sold over the counter due to their compact size and effectiveness in assisting patients with following their prescribed medication schedule. Tablets and capsules provide increased stability and extended shelf life, giving an advantage to manufacturers and healthcare organizations. Advancements in drug formulation and the availability of generic brands are expected to drive an increase in the usage of tablets and capsules for treating neuropathic pain, epilepsy, and anxiety disorders in the future.

By Application

Epilepsy

Neuropathic Pain

Other

By Distribution Channel

Hospital Pharmacies

Drug Store and Retail Pharmacies

Online Providers

GLOBAL PREGABALIN MARKET BY REGION

NORTH AMERICA

USA

Canada

Mexico

EASTERN EUROPE

Russia

Bulgaria

The Czech Republic

Hungary

Poland

Romania

Rest of Eastern Europe

WESTERN EUROPE

Germany

United Kingdom

France

The Netherlands

Italy

Spain

Rest of Western Europe

ASIA PACIFIC

China

India

Japan

South Korea

Malaysia

Thailand

Vietnam

The Philippines

Australia

New-Zealand

Rest Of APAC

MIDDLE EAST & AFRICA

Turkey

Bahrain

Kuwait

Saudi Arabia

Qatar

UAE

Israel

South Africa

SOUTH AMERICA

Brazil

Argentina

Rest of South America

To learn more about this report request a sample copy @

https://introspectivemarketresearch.com/request/16992

Key questions answered in the Pregabalin Market report are:

Which market segment dominated the global Pregabalin market in 2023?

What are the current global trends in the Pregabalin market?

What future industry applications and trends are emerging in the Pregabalin market?

What growth strategies are companies adopting to expand their presence in the Pregabalin market?

Who are the leading companies in the Pregabalin market, and what are their product portfolios?

What are the primary challenges that the Pregabalin market may face in the future?

Which region had the largest share of the Pregabalin market in 2023?

How is the regulatory environment influencing the Pregabalin market?

Key Offerings:

Market Size, Share, Size & Forecast by Different Segments | 2024−2032

Pregabalin Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region

Market Trend Analysis

Pestle Analysis

Porter’s Five Forces Analysis

Industry Value Chain Analysis

Ecosystem

Regulatory Landscape

Price Trend Analysis

Patent Analysis

Technology Evolution

Investment Pockets

Pregabalin Market Segmentation

Competitive Landscape – Profiles of selected key players in a strategic perspective

Competitive landscape – Competitive Benchmarking, Pregabalin Market Share by Manufacturer (2023), Industry BCG Matrix, Heat Map Analysis, Mergers & Acquisitions

Analyst Viewpoint and Conclusion

Introspective Market Research, a Healthcare firm has released the following reports:

Global Metoprolol Tartrate Market: The Metoprolol Tartrate Market Size Was Valued at USD 6.31 Billion in 2023 and is Projected to Reach USD 8.6 Billion by 2032, Growing at a CAGR of 3.5% From 2024-2032.

Global Anti Wrinkle Market: The Anti-Wrinkle Market Size Was Valued at USD 9,348.47 Million in 2023, and is Projected to Reach USD 17,923.26 Million by 2032, Growing at a CAGR of 7.50% From 2024-2032.

About us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Canada Office

Introspective Market Research Private Limited, 138 Downes Street Unit 6203- M5E 0E4, Toronto, Canada.

APAC Office

Introspective Market Research Private Limited, Office No. 401-403, Saudamini Commercial Complex, Chandani Chowk, Kothrud, Pune India 411038

Ph no: +1-773-382-1049

Email: sales@introspectivemarketresearch.com